Core Scientific director buys 6,000 shares at $16.33

A Core Scientific director bought additional shares in an open-market-type transaction and now directly holds over 265,000 shares.

Rhea-AI Filing Summary

Core Scientific, Inc. (CORZ) director Eric Stanton Weiss purchased 6,000 shares of Common Stock on September 15, 2026, in a purchase classified as an open market or private transaction at $16.33 per share. Following this trade, he directly holds 265,262 shares of Core Scientific common stock. No Rule 10b5-1 trading plan is reported for this transaction.

Insider Trade Summary

Net Buyer: 6,000 shares

Net Buy 1 txn

Insider Weiss Eric Stanton

Role Director

Bought 6,000 shs ($98K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	6,000	$16.33	$98K

Holdings After Transaction: Common Stock — 265,262 shares (Direct)

Key Figures

Shares purchased: 6,000 shares Purchase price: $16.33 per share Post-transaction holdings: 265,262 shares

3 metrics

Shares purchased 6,000 shares Common Stock bought on September 15, 2026

Purchase price $16.33 per share Price for the 6,000-share Common Stock purchase

Post-transaction holdings 265,262 shares Common Stock directly owned by Eric Stanton Weiss after the trade

Key Terms

Purchase in open market or private transaction, Rule 10b5-1 trading plan, direct ownership

3 terms

Purchase in open market or private transaction financial

"Transaction classified as a purchase in open market or private transaction"

Rule 10b5-1 trading plan regulatory

"No Rule 10b5-1 trading plan is reported for this transaction"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

direct ownership financial

"The filing classifies the 265,262 shares as direct ownership"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CORZ report for director Eric Stanton Weiss?

CORZ reported that director Eric Stanton Weiss purchased 6,000 shares of Common Stock on September 15, 2026, in a transaction classified as a purchase in an open market or private transaction at $16.33 per share.

How many Core Scientific (CORZ) shares does Eric Stanton Weiss hold after this transaction?

After the reported purchase, Eric Stanton Weiss directly holds 265,262 shares of Core Scientific, Inc. Common Stock, according to the Form 4 data.

At what price did the CORZ director buy the shares reported in this Form 4?

The reported transaction price was $16.33 per share for the 6,000 Core Scientific, Inc. Common Stock shares purchased on September 15, 2026.

Was the CORZ insider trade made under a Rule 10b5-1 trading plan?

No. The filing indicates that the Rule 10b5-1 checkbox is not affirmed, meaning no Rule 10b5-1 trading plan is reported for this 6,000-share purchase.

Is the reported CORZ insider ownership direct or indirect?

The filing classifies the 265,262 shares held after the transaction as direct ownership by Eric Stanton Weiss.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/17/2026 - 04:27 PM Accepted by SEC EDGAR 09/17/2026 - 04:26 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weiss Eric Stanton

(Last) (First) (Middle)

C/O CORE SCIENTIFIC, INC.

838 WALKER ROAD, SUITE 21-2105

(Street)

DOVER DELAWARE 19904

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Core Scientific, Inc./tx [ CORZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/15/2026		P		6,000	A	$16.33	265,262	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Todd DuChene, as Attorney-in-Fact	09/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)